BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33492607)

  • 1. CD8
    Lind L; Svensson A; Thörn K; Krzyzowska M; Eriksson K
    J Neurovirol; 2021 Feb; 27(1):145-153. PubMed ID: 33492607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.
    Hensel MT; Peng T; Cheng A; De Rosa SC; Wald A; Laing KJ; Jing L; Dong L; Magaret AS; Koelle DM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection.
    Wuest TR; Carr DJ
    J Immunol; 2008 Dec; 181(11):7985-93. PubMed ID: 19017990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.
    Thapa M; Kuziel WA; Carr DJ
    J Virol; 2007 Apr; 81(8):3704-13. PubMed ID: 17267483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice.
    de Lemos C; Christensen JE; Nansen A; Moos T; Lu B; Gerard C; Christensen JP; Thomsen AR
    J Immunol; 2005 Aug; 175(3):1767-75. PubMed ID: 16034118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.
    Thapa M; Carr DJ
    J Virol; 2009 Sep; 83(18):9486-501. PubMed ID: 19587047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 chemokine receptor guides Trypanosoma cruzi-specific T-cells triggered by DNA/adenovirus ASP2 vaccine to heart tissue after challenge.
    Pontes Ferreira C; Cariste LM; Ferri Moraschi B; Ferrarini Zanetti B; Won Han S; Araki Ribeiro D; Vieira Machado A; Lannes-Vieira J; Gazzinelli RT; Vasconcelos JRC
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007597. PubMed ID: 31356587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
    Stanford MM; Issekutz TB
    J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
    Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection.
    Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR
    J Infect Dis; 2019 Apr; 219(9):1430-1438. PubMed ID: 30496498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis.
    Zhang B; Chan YK; Lu B; Diamond MS; Klein RS
    J Immunol; 2008 Feb; 180(4):2641-9. PubMed ID: 18250476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system.
    Christensen JE; de Lemos C; Moos T; Christensen JP; Thomsen AR
    J Immunol; 2006 Apr; 176(7):4235-43. PubMed ID: 16547260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection.
    Nansen A; Marker O; Bartholdy C; Thomsen AR
    Eur J Immunol; 2000 Jul; 30(7):1797-806. PubMed ID: 10940868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice.
    Zimmermann J; Hafezi W; Dockhorn A; Lorentzen EU; Krauthausen M; Getts DR; Müller M; Kühn JE; King NJC
    J Neurovirol; 2017 Jun; 23(3):394-403. PubMed ID: 28116674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
    Komatsu K; Miyazaki D; Morohoshi K; Kuo CH; Kakimaru-Hasegawa A; Komatsu N; Namba S; Haino M; Matsushima K; Inoue Y
    Curr Eye Res; 2008 Sep; 33(9):736-49. PubMed ID: 18798077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtle CXCR3-Dependent Chemotaxis of CTLs within Infected Tissue Allows Efficient Target Localization.
    Ariotti S; Beltman JB; Borsje R; Hoekstra ME; Halford WP; Haanen JB; de Boer RJ; Schumacher TN
    J Immunol; 2015 Dec; 195(11):5285-95. PubMed ID: 26525288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection.
    Cook WJ; Kramer MF; Walker RM; Burwell TJ; Holman HA; Coen DM; Knipe DM
    Virol J; 2004 Sep; 1():5. PubMed ID: 15507126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response.
    Sørensen LN; Paludan SR
    Scand J Immunol; 2004 Mar; 59(3):321-33. PubMed ID: 15030585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.